Skip to content
lifestyle.thedishh.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Quantum BioPharma
Quantum Biopharma Provides Corporate Update
May 1, 2026
Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status
May 1, 2026
Quantum Biopharma Announces Appointment of Principal Investigator for Planned Phase 2 Clinical Trial of Lucid-21-302 (Lucid-MS) in Multiple Sclerosis
April 30, 2026
Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd
April 30, 2026
Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering
April 30, 2026
Quantum BioPharma Provides Corporate Update
April 28, 2026
Quantum BioPharma Provides Corporate Update
April 28, 2026
←
Previous Page
1
2